Sensus/$SRTS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Sensus
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
- Ticker
- $SRTS
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 60
- Headquarters
- Boca Raton, United States
- Website
- sensushealthcare.com
Sensus Metrics
BasicAdvanced
$56M
-
-$0.94
1.19
-
Price and volume
Market cap
$56M
Beta
1.19
52-week high
$5.49
52-week low
$2.66
Average daily volume
377K
Financial strength
Current ratio
8.707
Quick ratio
3.898
Long term debt to equity
0.002
Total debt to equity
0.009
Profitability
EBITDA (TTM)
-12.862
Gross margin (TTM)
36.39%
Net profit margin (TTM)
-88.45%
Operating margin (TTM)
-75.71%
Effective tax rate (TTM)
-21.95%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
-16.55%
Return on equity (TTM)
-34.83%
Valuation
Price to revenue (TTM)
3.193
Price to book
1.52
Price to tangible book (TTM)
1.52
Price to free cash flow (TTM)
-8.019
Free cash flow yield (TTM)
-12.47%
Free cash flow per share (TTM)
-0.425
Growth
Revenue change (TTM)
-53.39%
Earnings per share change (TTM)
1,719.04%
3-year revenue growth (CAGR)
-16.49%
10-year revenue growth (CAGR)
3.38%
3-year earnings per share growth (CAGR)
86.42%
10-year earnings per share growth (CAGR)
43.21%
Sensus Financial Performance
Revenues and expenses
Sensus Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.